Select Publications
Other
, 2025, Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.c.7761697
, 2025, Figure S1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051228
, 2025, Figure S2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051225
, 2025, Figure S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051222
, 2025, Figure S4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051219
, 2025, Figure S5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051216
, 2025, Figure S6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051213
, 2025, Sequence Coverage Report from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051210
, 2025, Supplementary Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051207
, 2025, Tables S1-S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.29051204
, 2025, Figure 1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760596
, 2025, Figure 2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760593
, 2025, Figure 3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760590
, 2025, Figure 4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760587
, 2025, Figure 5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760584
, 2025, Figure 6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760581
, 2025, Figure S1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760578
, 2025, Figure S2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760575
, 2025, Figure S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760572
, 2025, Figure S4 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760569
, 2025, Figure S5 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760566
, 2025, Figure S6 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760563
, 2025, Sequence Coverage Report from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760560
, 2025, Supplementary Data from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760557
, 2025, Table 1 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760554
, 2025, Table 2 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760551
, 2025, Tables S1-S3 from A Proteomic Signature for Human Papillomavirus–Associated Oropharyngeal Squamous Cell Carcinoma Predicts Patients at High Risk of Recurrence, http://dx.doi.org/10.1158/2767-9764.28760548